Spend $99, get free U.S. shipping*
Tariff now required on U.S. shipments. Learn more »
Tel: 1-866-456-3768 Fax: 1-866-544-8993
For visual reference only; actual product may vary
For visual reference only; actual product may vary
Synjardy is a dual-action prescription medicine for adults with type 2 diabetes. It combines empagliflozin and metformin to help lower blood sugar levels when diet, exercise, and metformin alone are not enough. This medication improves glycemic control and supports overall diabetes management in one convenient tablet.
| Synjardy Brand | 12.5mg / 500mg 60 Tablets |
-
|
Our price: $196.00 |
|
| Jardiance Duo Brand | 12.5mg / 1000mg 60 Tablets |
-
|
Our price: $164.00 |
|
| Jardiance Duo Brand | 12.5mg / 850mg 60 Tablets |
-
|
Our price: $99.00 |
|
| Jardiance Duo Brand | 5mg / 1000mg 60 Tablets |
-
|
Our price: $164.00 |
|
| Jardiance Duo Brand | 5mg / 850mg 60 Tablets |
-
|
Our price: $96.00 |
Synjardy is a prescription medication that combines two active ingredients, empagliflozin and metformin. It helps to improve blood sugar control in adults diagnosed with type 2 diabetes. This oral tablet is used along with diet and exercise. It is prescribed when treatment with metformin alone does not provide adequate control. Synjardy is not for treating type 1 diabetes. It helps manage a complex metabolic disorder. This disorder involves both insulin resistance and a deficiency in insulin production.
Synjardy works in two complementary ways to lower high blood sugar levels. The first component, empagliflozin, is an SGLT2 inhibitor. It helps the kidneys remove glucose from your bloodstream through urination. The second component, metformin, works differently. It lowers the amount of glucose produced by your liver. It also increases your body’s sensitivity to insulin. This dual-action approach provides more effective blood sugar management than either drug alone. It tackles key pathways involved in type 2 diabetes.
Synjardy is prescribed for adults with type 2 diabetes to improve their glycemic control. It is intended for patients whose blood sugar is not well-managed by metformin alone. This medication is suitable for those needing additional help to reach their blood sugar targets. It can also replace separate tablets of empagliflozin and metformin. This offers a more convenient dosing schedule. Patients must have adequate kidney function to take this medication safely. A doctor will evaluate your health to see if it is right for you.
Synjardy tablets are typically taken twice daily with meals to reduce stomach upset. It is very important to swallow the tablets whole. Do not crush, cut, or chew them. Your doctor will determine the correct starting dose and strength for you. The dose depends on your current diabetes medications and kidney function. Always follow your healthcare provider’s instructions carefully. If you miss a dose, take it when you remember. But if your next dose is near, skip the missed one. Never take two doses at once.
Synjardy can cause side effects, although not everyone will experience them. Your doctor has determined the benefits outweigh the potential risks. Seek immediate medical help for an allergic reaction. Symptoms include face or throat swelling, breathing trouble, or hives. The medicine has a risk of lactic acidosis. This is a rare but serious condition. Common side effects may include:
Less common side effects can include dehydration and dizziness. Talk with your doctor if any side effects persist or worry you. Always read the patient information leaflet before starting.
IsraelPharm offers a convenient and affordable way to purchase your essential medications. We provide access to brand-name drugs, like Synjardy, from a trusted and reliable source. Our simple online ordering process saves you time and trips to the pharmacy. Every order is reviewed by a licensed pharmacist to ensure safety and accuracy. Our dedicated customer service team is available to help with any questions. We are committed to making your medications more accessible. Experience the ease and savings of ordering with IsraelPharm for your healthcare needs.
Synjardy may cause side effects, though most users experience none. It is critical to get emergency medical help if you have signs of a severe allergic reaction. These signs include hives, difficulty breathing, or swelling of your face, tongue, or throat.
This medication also carries a risk of lactic acidosis, a rare but serious side effect related to metformin. Seek help if you feel very weak, tired, or have unusual muscle pain.
Synjardy is used to treat adult type 2 diabetes, a metabolic disorder caused by insulin resistance and deficiency. It is prescribed alongside diet and exercise to improve blood sugar control. Symptoms of uncontrolled diabetes include:
Synjardy is a prescription medication used to improve blood sugar control in adults with type 2 diabetes. It combines two medicines, empagliflozin and metformin, into a single tablet. It is intended to be used together with a healthy diet and regular exercise program. This medication helps lower blood glucose levels and manage the condition more effectively.
Synjardy should be taken exactly as prescribed by your healthcare provider. The usual dosage is one tablet taken twice daily with your meals. Taking it with food helps reduce the risk of stomach upset. The tablets must be swallowed whole and should not be crushed, chewed, or split, as this can affect how the medicine works.
If you miss a dose of Synjardy, you should take it as soon as you remember. However, if it is almost time for your next scheduled dose, it is best to skip the missed one. Do not take two tablets at the same time to make up for a missed dose, as this could increase your risk of side effects.
Synjardy and alcohol can be a risky combination. Drinking alcohol, especially in large amounts, can significantly increase your risk of developing lactic acidosis, a rare but very serious side effect of the metformin in Synjardy. It is safest to limit or avoid alcohol consumption while on this medication. Always discuss your alcohol use with your doctor.
The most common side effects of Synjardy include urinary tract infections and genital yeast infections. Low blood sugar, or hypoglycemia, can also occur, particularly if you take it with other diabetes medications like insulin. Nausea, increased urination, and thirst are also frequently reported. If these side effects are bothersome or do not go away, contact your doctor.
Synjardy can contribute to modest weight loss in some people with type 2 diabetes. This effect is thought to be from the empagliflozin component, which causes your body to get rid of extra sugar and calories through urine. However, Synjardy is not a weight-loss drug. It is part of a larger treatment plan that includes diet and exercise.
Synjardy begins working to lower your blood sugar levels within the first few hours after you take it. However, you may not notice the full benefits on your overall blood sugar control for one to two weeks. Consistent use according to your doctor’s instructions is key to achieving the best results for managing your type 2 diabetes.
Synjardy is not the same as metformin, but it does contain metformin as one of its two active ingredients. The other active ingredient is empagliflozin. This combination medication offers a dual-action approach to lowering blood sugar that is more effective for some patients than taking metformin by itself. It provides the benefits of both drugs in a single pill.
Synjardy may be prescribed along with insulin for some adults with type 2 diabetes to achieve better blood sugar control. Your doctor will make this decision based on your individual health needs. Using Synjardy with insulin can increase the risk of low blood sugar (hypoglycemia), so it is important to monitor your levels closely as directed by your healthcare provider.
Synjardy works best as part of a complete diabetes management program. Your doctor will recommend that you follow a healthy, balanced diet and participate in regular physical activity. These lifestyle changes are essential for managing blood sugar levels and improving the overall effectiveness of your medication. Synjardy is a tool to help your efforts, not a replacement for them.
Synjardy is not recommended for patients who already have severe kidney disease. The empagliflozin in the medication works through the kidneys. Your doctor will test your kidney function before you start taking Synjardy and will monitor it periodically during your treatment. This is done to ensure the medication remains safe for you to use.
Synjardy treatment includes a risk of lactic acidosis, which is a rare but serious medical emergency. It is caused by a buildup of metformin in the blood. Symptoms can be subtle and include muscle pain, trouble breathing, stomach pain, and feeling very tired or weak. If you experience these symptoms, you should seek emergency medical help right away.
Synjardy should be stored at room temperature, below 77°F (25°C). Keep the tablets in their original container to protect them from moisture and heat. It is important to keep this and all medications out of the reach of children and pets. Do not store them in a bathroom where humidity is high. Discard any unused medication after the expiration date.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
Glucagon-like peptide-1 (GLP-1) receptor agonists are medications prescribed for managing type 2 diabetes and, increasingly, for weight loss. These drugs, which include well-known brands like Ozempic, Mounjaro, Zepbound, and Wegovy, represent a significant advancement in
It can be one of the most frustrating experiences: you commit to a healthier lifestyle, you watch what you eat, you increase your activity, but the scale refuses to reward you. This struggle can feel
I have to admit, until very recently, I had never heard of Pelvic Congestion Syndrome. My attention was drawn just this week to an article from the Mayo Clinic, one of my regular sources of
